Clinical trial
Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being…
NCT00384423 · Epix Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00384423 |
|---|---|
| Title | Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study to Assess the Short-Term Effects of PRX-03140 Alone and in Combination With Donepezil in Subjects With Mild Alzheimer's Disease. |
| Lead sponsor | Epix Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | PRX-03140 |
| Enrollment | 80 |
| Start date | Oct 1, 2006 |
| Primary completion | Oct 1, 2007 |
| First posted | Oct 6, 2006 |
| Last update posted | Jan 30, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: